FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
about
Inhibitor of ppGalNAc-T3-mediated O-glycosylation blocks cancer cell invasiveness and lowers FGF23 levels.Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunitiesPotential application of klotho in human chronic kidney disease.Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression.Tumour-induced osteomalacia.Enpp1 is an anti-aging factor that regulates Klotho under phosphate overload conditions.Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
P2860
Q33611054-53E04D68-B43D-4166-A252-B51F83C7FB0EQ36447553-3F200245-614F-4C86-ACC6-7223A112D9A1Q39003568-26F6691C-B699-4754-878D-69F37035C7C2Q39093915-C8AEE54A-D894-41D7-BF5C-F0CD1611ECFBQ39432298-0EC86F26-871D-454F-A956-F004B027883BQ41354101-B08260DF-CCB9-430A-B924-9F3793D56089Q55030185-44CF6B29-FEB8-4B7A-B675-E13E3A0CDFEFQ55388960-1EBE3C96-CB8B-4C1B-958B-EB432AA5FE23
P2860
FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
FGF23-FGF Receptor/Klotho Path ...... f Bone and Mineral Metabolism.
@en
type
label
FGF23-FGF Receptor/Klotho Path ...... f Bone and Mineral Metabolism.
@en
prefLabel
FGF23-FGF Receptor/Klotho Path ...... f Bone and Mineral Metabolism.
@en
P2860
P1476
FGF23-FGF Receptor/Klotho Path ...... of Bone and Mineral Metabolism
@en
P2093
Seiji Fukumoto
P2860
P2888
P304
P356
10.1007/S00223-015-0029-Y
P407
P577
2015-07-01T00:00:00Z
P6179
1047954680